Clinicopathological study of invasive extramammary Paget's disease: Subgroup comparison according to invasion depth

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 5, 2013, Pages 589-592

  Shiomi, T ^a   Noguchi, T ^b   Nakayama, H ^b   Yoshida, Y ^a   Yamamoto, O ^a   Hayashi, N ^b   Ohara, K ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MITOSIS; PAGET SKIN DISEASE; PRIORITY JOURNAL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PAGET DISEASE, EXTRAMAMMARY;

EID: 84876110835     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04489.x     Document Type: Article

References (16)

1. Lloyd J, Flanagan AM,. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53: 742-749.
2. Crocker HR,. Paget's disease affecting the scrotum and penis. Trans Pathol Soc Lond 1889; 40: 187-191.
3. Aoyagi S, Akiyama M, Shimizu H,. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease. J Dermatol Sci 2008; 50: 177-184.
4. Barnhill RL,. Textbook of Dermatopathology, 2nd edn. McGraw-Hill Companies, New York, 2004: 770-772.
5. LeBoit PE, Burg G, Weedon D, Sarsain A, eds. World Health Organization Classification of Tumours. Pathology and Genetics Skin Tumours. IARC, Lyon, 2006: 13-19, 20-25, 137-138.
6. Ellis PE, Fong LF, Rolfe KJ, et al. The role of p53 and Ki-67 in Paget's disease of the vulva and the breast. Gynecol Oncol 2002; 86: 150-156.
7. Weedon D,. Skin Pathology, 2nd edn. Churchill Livingstone, New York, 2002: 883-884.
8. Chen S, Moroi Y, Urabe K, et al. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease. Clin Exp Dermatol 2008; 33: 634-640.
9. Yamada Y, Matsumoto T, Arakawa A, et al. Evaluation using a combination of lymphatic invasion on D2-40 immunostain and depth of dermal invasion is a strong predictor for nodal metastasis in extramammary Paget's disease. Pathol Int 2008; 58: 114-117.
10. Ohnishi T, Watanabe S,. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol 2000; 142: 243-247.
11. Feuer GA, Shevchuk M, Calanog A,. Vulvar Paget's disease: the need to exclude an invasive lesion. Gynecol Oncol 1990; 38: 81-89.
12. Shaco-Levy R, Bean SM, Vollmer RT, et al. Paget Disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course. Int J Gynecol Pathol 2010; 29: 69-78.
13. Murata Y, Kumano K, Tani M,. Underpants-pattern erythema: a previously unrecognized cutaneous manifestation of extramammary Paget's disease of the genitalia with advanced metastatic spread. J Am Acad Dermatol 1999; 40: 949-956.
14. Fine BA, Fowler LJ, Valente PT, et al. Minimally invasive Paget's disease of the vulva with extensive lymph node metastases. Gynecol Oncol 1995; 57: 262-265.
15. Ewing T, Sawicki J, Ciaravino G, et al. Microinvasive Paget's disease. Gynecol Oncol 2004; 95: 755-758.
16. Rubio CA,. Arrest of cell proliferation in budding tumor cells ahead of the invading edge of colonic carcinoma. A preliminary report. Anticancer Res 2008; 28: 2417-2420.